NCPDP Announces Elite Partner Program, Welcomes CoverMyMeds as Inaugural Elite Partner

 

SCOTTSDALE, AZ and COLUMBUS, OH, October 28, 2014 -- NCPDP and CoverMyMeds announced today that CoverMyMeds has signed on as the Inaugural Elite Partner in NCPDP’s new Elite Partner Program. NCPDP’s Elite Partner Program establishes the highest level of sustained support for the valuable work of NCPDP in advancing patient safety and interoperability. NCPDP will accept a total of ten partners into its Elite Partner Program.

“We are pleased to welcome CoverMyMeds as our Inaugural Elite Partner,” explained Lee Ann Stember, President of NCPDP. “The actionable industry standards and guidance created by NCPDP through the expertise, dedication, and volunteerism of our members continues to have a profound impact on improving patient safety and enhancing clinical and financial efficiencies of the healthcare ecosystem. As our Inaugural Elite Partner, CoverMyMeds has demonstrated its intense commitment to support our work, mission and core values.”

“We are excited to be the Inaugural Elite Partner, and show our support for the valuable standards development work of NCPDP,” said Matt Scantland, Co-founder of CoverMyMeds. “As the leader in electronic prior authorization, we are deeply committed to accelerating industry-wide adoption of the new ePA transactions in the NCPDP SCRIPT Standard to ensure that all patients benefit as quickly as possible from this new technology.”

For information on how to participate in NCPDP’s Elite Partner Program, contact Phillip Scott, Senior VP, Business Development, NCPDP.

About NCPDP 
Founded in 1977, NCPDP is a not-for-profit, ANSI-accredited, Standards Development Organization with 1,600 members representing virtually every sector of the pharmacy services industry. Our diverse membership provides leadership and healthcare business solutions through education and standards, created using the consensus building process. NCPDP has been named in federal legislation, including HIPAA, MMA, and HITECH. NCPDP members have created standards such as the Telecommunication Standard and Batch Standard, the SCRIPT Standard for ePrescribing, the Manufacturers Rebate Standard and more to improve communication within the pharmacy industry. Our data products include dataQ®, a robust database of information on more than 76,000 pharmacies, and HCIdea®, an innovative prescriber database that provides continually updated information on more than two million prescribers. NCPDP's RxReconn® is a legislative tracking product for real-time monitoring of pharmacy-related state and national legislative and regulatory activity. For more information about NCPDP Standards, Data Services, Products, Educational Programs and Work Group meetings, go online athttp://www.ncpdp.org or call (480) 477-1000.

About CoverMyMeds 
CoverMyMeds is the leader in Prior Authorization and one of the fastest growing healthcare technology companies in the US. We help physicians, pharmacists, and their staff complete PA requests for any drug and all plans. Our technology integrates with pharmacy systems, EHRs, and PBMs to create the most efficient electronic prior authorization (ePA) strategy for all participants. With a million PAs submitted each month, CoverMyMeds is the only vendor using the NCPDP ePA standard at scale. For more information, visit http://www.covermymeds.com.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.